Hims & Hers Health (NYSE:HIMS) verzeichnete am Donnerstag, den 21. November, einen Kursanstieg von etwa 10 %, nachdem ein Bundesgericht…
Hims & Hers Health expands board, appoints new director…
Shares of healthcare company Hims Hers Health ($HIMS) surged on Thursday after a Texas court temporarily paused a case…
Hims & Hers Health ( ($HIMS) ) has provided an update. Hims & Hers Health, Inc. has expanded its board…
HIM & Hers Health stock rises after federal court closes case on FDAs GLP-1 tirzepatide shortage determination. Read more here.…
Citi notes that the FDA said in a status report filed in a Texas court that it needs more time…
A joint status report that was filed in the U.S. District Court for the Northern District of Texas states in…
Hims Hers Health (HIMS) announced that Hims Hers customers will now be able to supplement their treatment plan…
Hims & Hers Health expands weight management offerings with new protein bars and shakes subscription program, starting at $110/month. Includes…
SAN FRANCISCO, November 21, 2024--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform,…
Investors in Hims & Hers Health Inc (Symbol: HIMS) saw new options become available today, for the January 2025 expiration.…
Landscape Capital Management L.L.C. trimmed its holdings in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report)…
Principal Financial Group Inc. boosted its holdings in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report)…
Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) has been assigned an average rating of "Hold" from the…
Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that Hims…
To help its customers stay on top of their protein and nutrient intake and simplify access to the critical nutrition…
…
Hims & Hers financials are robust, with strong and accelerating revenue growth, growing free cash flow, manageable SBC, and no…
TD Cowen reaffirms Buy rating on Hims and Hers stock, highlights FDA case impact…
Connor Clark & Lunn Investment Management Ltd. lessened its position in shares of Hims & Hers Health, Inc. (NYSE:HIMS…
Hims & Hers Health (NYSE:HIMS) Shares Gap Down - Whats Next?…
Shares of Hims & Hers Health Inc (HIMS) surged 8.64% in mid-day trading on Nov 19. The stock reached an…
By Dean Seal Shares of Hims & Hers Health jumped after the company added former Food and Drug Administration official…
Hims & Hers ist für mich die überzeugendste Kaufgelegenheit in einem sonst teuren Marktumfeld. Amazons "neues” Konkurrenzangebot verdeutlicht erneut, dass…
Hims Hers Health, announced Deb Autor, former deputy commissioner at the FDA, will join the company’s board of directors,…
Hims & Hers Health strengthens clinical excellence with two strategic appointments: former FDA deputy commissioner Deb Autor joins board, while…
Former FDA deputy commissioner and former Pfizer & Hillrom quality executive join Hims & Hers, deepening the leadership that drives…
Royce & Associates LP raised its stake in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 17.0%…
Hims & Hers Health, Inc. (“Hims & Hers”) (NYSE: HIMS), the leading health and wellness platform, today announced Deb Autor,…
We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on Substack by The Dutch Investors. In…
We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on Substack by The Dutch Investors. In this article,…
Shares of Hims & Hers (NYSE: HIMS) is down big this week after Amazon (NASDAQ: AMZN) announced its expansion into…
Motley Fool Press Release.…
Hims & Hers has given back recent gains, but dont overlook the companys massive growth.…
Hims & Hers has given back recent gains, but dont overlook the companys massive growth.…
Hims & Hers (NYSE: HIMS) is disrupting the healthcare market with its innovative patient treatment approach.…
Hims & Hers (NYSE: HIMS) is disrupting the healthcare market with its innovative patient treatment approach. Stock prices used were…
Hims & Hers (NYSE: HIMS) is disrupting the healthcare market with its innovative patient treatment approach.…
Hims & Hers offers personalized telehealth services, with a stock price that reflects high-growth potential. See why we recommend a…
…
Hims & Hers Healths stock dropped 25% due to Amazon’s competition. Learn why HIM stocks 38% upside and strong growth…
…
Hims & Hers sees explosive growth with plans to launch generic GLP-1 drugBusiness is booming for online health and wellness…
Hims & Hers Health (HIMS) erlebte einen Rückschlag, nachdem Amazon (AMZN) eine Anpassung in ihrem One Medical Pay-per-Visit Telemedizin-Programm ankündigte. Die…
HIMS stock sees its worst-ever drop as Amazon threatens to undercut its core business…